Abstract
While being a relatively prevalent condition particularly among aging patients, peripheral arterial disease (PAD) of lower extremities commonly goes undetected or misdiagnosed due to its symptoms being nonspecific. Additionally, progression of PAD in the absence of timely intervention can lead to dire consequences. Therefore, development of non-invasive and affordable diagnostic approaches can be highly beneficial in detection and treatment planning for PAD patients. In this study, we present a contrast-free ultrasound-based quantitative blood flow imaging technique for PAD diagnosis. The method involves monitoring the variations of blood flow in the calf muscle in response to thigh-pressure-cuff-induced occlusion. Four quantitative metrics are introduced for analysis of these variations. These metrics include post-occlusion to baseline flow intensity variation (PBFIV), total response region (TRR), Lag0 response region (L0RR), and Lag4 (and more) response region (L4 + RR). We examine the feasibility of this method through an in vivo study consisting of 14 PAD patients with abnormal ankle-brachial index (ABI) and 8 healthy volunteers. Ultrasound data acquired from 13 legs in the patient group and 13 legs in the healthy group are analyzed. Out of the four utilized metrics, three exhibited significantly different distributions between the two groups (p-value < 0.05). More specifically, p-values of 0.0015 for PBFIV, 0.0183 for TRR, and 0.0048 for L0RR were obtained. The results of this feasibility study indicate the diagnostic potential of the proposed method for the detection of PAD.
Similar content being viewed by others
Introduction
Peripheral arterial disease (PAD) generally refers to a progressive circulation disorder, characterized by narrowing or occlusion of the peripheral arteries1. Lower extremity PAD is the most common form of PAD affecting more than 8.5 million Americans and more than 230 million patients worldwide2,3. While traditional atherosclerotic risk factors participate in the development of PAD, nicotine addiction with habitual smoking is considered the most prevalent risk for these patients, and diabetes mellitus is likewise an important variable4,5. An early and the most common clinical presentation of PAD is intermittent claudication, which involves pain in the lower limb (particularly the calves) mainly induced by physical activities such as walking and subsiding by rest6,7. While PAD associated walking impairment adversely influences quality of life for PAD patients, there is an added elevated risk of developing major adverse cardiac events including myocardial infarction, stroke, heart failure and both cardiovascular death and all-cause mortality8,9,10. Beyond intermittent claudication and major adverse cardiac events, severe PAD can lead to critical limb ischemia which if untreated, might result in leg amputation and a high mortality rate as a result11. Therefore, early diagnosis of PAD and proper implementation of guideline indorsed risk factor modification is paramount for effective management of these patients12.
Customary clinical diagnostic and monitoring methods for peripheral arterial disease include the use of different imaging modalities such as duplex ultrasonography, computed tomography (CT) and magnetic resonance (MR) angiography13,14,15. For disease screening, symptom evaluation, and periodic disease monitoring, a non-invasive evaluation is more appropriate and involves Doppler assessment and measurement of the ankle brachial index (ABI)16. ABI values in the range of 0.9 to 1.4 are considered as normal17,18. Values less than 0.9 indicate the presence of arterial disease19 with values below 0.5 consistent with severe PAD, suggestive of critical limb ischemia20. While readily available, easy to perform, and reproducible, the resting ABI assessment may have limited accuracy in conditions such as diabetes mellitus, chronic kidney disease, arterial calcification, isolated iliac arterial disease and in the elderly21,22. Furthermore, ABI may be insensitive to microvascular impairment, which may coexist with macrovascular disease in PAD patients23,24,25,26. Therefore, normal ABI does not rule out PAD and values greater than 1.4, may indicate high stiffness and poorly compressible arteries (mostly due to arterial calcification)27,28. As a result, in such cases, the severity of PAD cannot be properly evaluated.
Arteriolar endothelial function, microvascular regulation and responsiveness to specific stimuli are impaired in patients with PAD which may play a central role in disease development and progression29,30,31,32. The impaired microvascular reactivity expresses the imbalance between vasodilators and vasoconstrictors, such as nitric oxide and endothelin, respectively. One study reported the assessment of microvascular reactivity by hyperemic response to contraction and cuff occlusion using BOLD imaging33. Moreover, in response to chronic metabolic demand in PAD, vascular remodeling include increased diameter and density of microcirculations to accommodate the increased blood flow34. Studies suggest that progression of the peripheral arterial disease can lead to disruptions in blood distribution and flow in the muscles of the lower extremity, thus creating the conditions that result in intermittent claudication35,36,37. Many of these studies are performed using MR38,39,40 and CT-based imaging methodologies41,42.
In recent years, there has been growing interest in investigating the microvascular flow and muscle perfusion in PAD. However, the use of non-invasive imaging modalities for PAD diagnosis, such as duplex ultrasonography, has been limited to the evaluation of macrovascular blood flow43,44. Emergence of plane wave ultrasound imaging has shown promise in quantitative high resolution blood flow imaging without the use of contrast agents45,46,47,48. Several studies have examined the practicability of novel ultrasound microvasculature and perfusion imaging strategies for evaluation of blood flow variations in patients with PAD49. While studies using contrast agents have shown promise for assessing slow flow in small vasculature50,51,52,53,54, there is a need for more accessible and cost-effective methods that do not require contrast agents.
Monitoring and analysis of the reactive hyperemic response in the lower limb to externally induced occlusion can have diagnostic significance. It is known that a reduction in peak muscle perfusion capacity occurs in response to ischemic provocation tests, such as thigh-cuff occlusion 55. We hypothesize that by evaluating the blood flow variations of the lower extremity in response to thigh-cuff occlusion, we can identify PAD-affected legs. In this paper, a novel pressure-based method is proposed for flow imaging that can assess microvascular reactivity using ultrasound. The method measures the changes in microvascular blood flow in the calf muscles in response to a mechanical stimulus, which can be used to assess the function of the microvasculature in the lower extremities. We demonstrate how the measured metrics can provide potential diagnostic information about the conditions of patients in comparison to their ABI evaluations.
Results
Response analysis
In this section, we present a comparison of the results of our methodology for a 72-year-old female PAD patient clinically diagnosed with moderate PAD in the left leg and the results for the left leg of a healthy 62-year-old female volunteer. Resting ABI values for the left leg of the PAD patient measured at the dorsalis pedis (DP), and the posterior tibial (PT) arteries are reported as 0.62 and 0.61, respectively.
Comparative illustration of the results for the aforementioned cases is displayed in Fig. 1. Figures 1a and g show example B-mode images of scanned area. Obtained Doppler frames after the pressure release point (PRP) are shown in Fig. 1b and h. Binarized correlation masks are presented in Fig. 1c and i. These masks show pixels at which temporal Doppler signals have a correlation larger than 0.5 with the single frame lag activation function. Comparing the two figures, fewer pixels demonstrate a correlated behavior with the activation function (i.e., a rapid hyperemic response to pressure release) in the case of the PAD patient. Figures 1d and j illustrate the lag images for the healthy and affected legs, respectively. Dark blue regions represent lag0 (no lag) pixels where an immediate surge of flow occurs. A larger region is covered by such pixels in Fig. 1d compared to Fig. 1j. Figures 1e and k show the average of the normalized temporal Doppler signals (red line) for all pixels within the correlation masks, as well as the single frame lag activation function (blue line), for 10 frames before PRP up to PRP, exhibiting a sharp increase in the amplitude of the signal at the time of pressure release in correlation with the activation function. The shaded area around the red line in light blue shows half of the standard deviation of variations for all pixels on each side of the line. Figures 1f and l depict the average of the Doppler intensities of the pixels inside the correlation masks at each Doppler frame. These variations demonstrate the hemodynamic response to cuff inflation (green circles) and deflation (red circles). The inflation and deflation frames are chosen as the Doppler frames that are closest in time to the actual inflation and deflation events during the study. The general trend in the responses indicates a decline in flow after inflation and a rise and gradual fall after deflation. A more intense and rapid response to pressure release is observed in Fig. 1f compared to Fig. 1l.
A summary of the calculated metric values is presented in Table 1. The corresponding box-and-whisker plots of the distributions of the metrics for the two groups are also illustrated in Fig. 2. The post-occlusion to baseline flow intensity variations (PBFIV) show the net increase in Doppler intensity with respect to the average baseline Doppler intensity. This parameter shows an average of 672 percent increase in Doppler intensity in response to pressure release for the healthy leg compared to 123 percent for the affected legs. Total response region (TRR) represents the percentage of the pixels that have a higher than 60 percent correlation with at least one shifted version of the multiple frame lag activation function. This region constitutes an average of about a 3.61 percent of the entire scanning region for the PAD cases compared to 7.42 percent for the healthy group. Finally, based on the lag images, in the case of affected legs, for nearly 1.99 percent of the scanned area on average, it takes at least four (or more) frames to manifest a hyperemic response (if they do so at all), while this value is about 1.61 percent for the healthy subjects (L4 + RR). On the other hand, an average of about 37.19 percent of the region demonstrates an immediate (lag 0) flow compensation in the case of healthy legs compared to 22.60 percent in the case of affected legs. In total, three out of the four utilized metrics exhibited a significant (p-value > 0.05) distributional difference between the two groups.
Discussion
In this study, we introduced a contrast-free ultrasound imaging framework for evaluation of blood flow variations in response to pressure cuff occlusion in PAD patients as well as healthy subjects. Post-processing and analysis help in visualization and evaluation of flow changes and quantification metrics can have diagnostic potential.
There exist several studies in the literature for monitoring blood flow and perfusion changes in the lower extremity in patients with PAD using different imaging modalities including MRI56, CT57, and contrast-enhanced ultrasound58 imaging. The potential and significance of the current study lies in its use of simple, inexpensive, and accessible ultrasound imaging without the added burden of injecting contrast agents. This can potentially preclude further discomforts and expenses for the patients, as ultrasound is commonly used for screening purposes.
Implementation of the proposed method on patients with clinically diagnosed PAD (based on ABI evaluation) and healthy subjects suggest that there might be observable differences between the hemodynamic response of affected legs in PAD patients to pressure cuff induced occlusion compared to the legs of healthy individuals. Correlation masks presented in Fig. 1c and i show examples of a healthy leg and an affected leg, respectively, where a larger region exhibits an immediate flow compensation (high correlation with the activation function) in the healthy case.
The normalized average Doppler Intensity variations in the Doppler frames leading up to the point of pressure release (as shown in Fig. 1e and k) exhibit how in both cases blood flow compensation follows the activation function at PRP. The normalized values of Doppler intensities (red curves), however, are slightly lower in the healthy case. This is expected, as these values are normalized by the maximum intensity at PRP, and therefore a lower normalized value is equivalent to a higher increase in blood flow as a response to pressure release.
Doppler intensity variations as shown in Fig. 1f and l illustrate how in both cases there is a general decline in the amount of blood flow as a response to pressure cuff inflation (points after the green circles). Similarly, there is a rapid increase in the Doppler intensity following pressure release points (red circles). This hyperemic response to cuff occlusion has been observed in other studies54,59. Nonetheless, several differences are noticeable between the two intensity profiles. As reported in Table 1, the average relative post-occlusion increase in Doppler intensities compared to baseline for PAD patients is about 123 percent, while this value is 672 percent for the healthy subjects. This is in keeping with several studies suggesting reduced reactive response in leg blood flow for PAD patients60. Another observation in the Doppler intensity profiles is the slower decline in post-occlusion response in the case of the PAD patient. Additionally, peak Doppler intensity seems to occur a few frames after pressure release (as opposed to the healthy case, where the peak appears immediately following pressure release). This phenomenon has been reported in the literature where PAD subjects generally exhibit a faster perfusion increase as well as a more rapid drop in perfusion post occlusion23.
The delayed response in the case of PAD patients is also quantified via the percentage of no lag pixels (L0RR) and the pixels with a lag of four frames and more (L4 + RR). This is in keeping with observations in the literature where the time to peak response in PAD patients is reportedly significantly higher55.
There are some limitations associated with the current study. Firstly, the number of subjects included in the analysis for this study was limited. In the future, we plan to study on a large patient population, PAD patients as well as healthy volunteers, to evaluate the performance of the introduced technique in differentiating between the two groups based on the quantification metrics. We also plan to incorporate exercise as part of our setup to evaluate the combined post-exercise and post-occlusion responses for enhanced differentiation between affected and unaffected lower limbs.
Methods
In vivo study
To evaluate the efficacy of our methods, imaging studies were conducted for 14 patients with clinical diagnosis of PAD (7 male, 7 female), and 8 healthy volunteers (1 male, 7 female). Age distribution of the patients and healthy subjects was 65.9 ± 16.3 and 64.1 ± 2.8, respectively (mean ± standard deviation). This study was approved by the institutional review board at the Mayo Clinic (IRB#: 19-002559) and was in compliance with the Health Insurance Portability and Accountability Act. All the research was performed in accordance with relevant guidelines/regulations and followed the Declaration of Helsinki. A written IRB approved informed consent form was signed by each participant prior to the study. Patients were recruited based on their clinical ABI examination. Recruitment for the healthy group involved aiming for non-smoker individuals with no history of diabetes or relevant underlying diseases. During the study, both legs of the subjects were scanned. For final data analysis, data from legs of patients with normal ABI, as well as poor data acquisitions were excluded. After exclusions, data from a total of 13 legs with abnormal ABI were compared to data from 13 legs of healthy individuals.
Data acquisition
Data acquisition was performed using a linear array L11-4v probe (with a center frequency of 7.24 MHz) attached to a Verasonics Vantage 256 ultrasound research system (Verasonics Inc., Kirkland, WA, USA). Ultrafast ultrasound imaging was implemented through coherent compounding of plane wave transmissions at five different insonification angles equally spaced within the [− 5.5° +5.5°] range. Each transmission sequence involved acquiring 500 IQ data frames at a frame rate of 2 kHz and was repeated every 2 s to monitor the flow response over time.
Experimental setup
With subjects in the supine position, the targeted leg was placed on a stand-alone leg prepper. The ultrasound probe was attached to the subject’s calf muscle for imaging and was secured in place using a multi-joint mechanical arm. A pressure cuff was wrapped around the subject’s thigh and an automatic cuff inflation device (D. E. Hokanson Inc., Bellevue, WA, USA) was used for rapid inflation of the cuff. A schematic illustration of the setup is shown in Fig. 3. Ultrasound data was continuously collected for 7 min per each leg. The setup consisted of one minute of baseline data acquisition, followed by three minutes of pressure-induced occlusion and three minutes of post-occlusion data acquisition. Figure 4 depicts a schematic of the timeline of the acquisition setup, as well as examples of Doppler images corresponding to each portion of the study.
Doppler image generation
The 500 IQ data frames acquired during each transmission sequence constitute an ensemble of ultrasound images that was used to generate a Doppler image visualizing blood flow intensities at a given point in time. These frames were first reshaped into a spatiotemporal/Casorati data matrix. Next, a singular value decomposition (SVD) filter was applied to the data to remove the low-rank tissue clutter. In this study, the SVD threshold for the separation of clutter and blood subspaces was chosen empirically and was set to the constant value of 50 for all the Doppler frames (no upper threshold for noise removal). Subsequently, the clutter filtered data frame ensemble underwent a temporal coherent integration to generate the Doppler image.
The resulting Doppler image was composed of signals generated by blood flow as well as noise. The background noise profile (mainly induced by the time gain compensation (TGC) settings) can be estimated and compensated for, through various means61,62. In this work, we used a Doppler image generated from an open-air transmission to estimate this profile. Since no significant echo signal was expected in such a transmission, the resulting image would be a good approximation of the TGC-induced noise pattern. Considering the TGC-induced noise was removed after the implementation of SVD, it did not have a direct influence on our choice of the SVD threshold. We then subtracted this noise profile from each of the Doppler images to generate a final flow image. We refer to each of these images as a Doppler frame. Figure 5 illustrates different stages of generating these Doppler frames.
Hemodynamic analysis
The generated Doppler images illustrate the hemodynamic variations in the calf muscle. These variations can be quantified as a function of time, in a time series with a sampling period of 2 s. To monitor the hyperemic response to the pressure induced occlusion, we define a single lag activation step function to represent the onset of the stimulation (pressure release) at the “Deflate” (pressure release) point. We then correlate the Doppler intensity variations from 10 Doppler frames before, up until one frame after the point of pressure release. This results in a correlation value for each pixel in the Doppler image showing its consistency with the expect hyperemic response, together constituting a correlation map after pressure release. Using a threshold on these maps, a binarized image is generated depicting all the pixels that exhibited a compensatory flow response, including muscle perfusion. This threshold was set to 0.5 in this study to strike a balance between the inclusion of slow responding flow elements (such as muscle perfusion signals) and the inclusion of noise. We refer to these binarized images as correlation masks. These correlation masks are utilized to monitor Doppler intensity alterations, by averaging the masked Doppler signal magnitude as a function of Doppler frame sample time for the duration of the study. These temporal intensity profiles can then be used to estimate post-occlusion Doppler intensity variations with respect to the baseline. Therefore, we define a metric called “post-occlusion to baseline flow intensity variation” (PBFIV) as the percentage-wise ratio of the difference between average post-occlusion and average baseline flow intensities over the average baseline intensity:
\(I_{{Post - occ - 5frames_{mean} }}\) is the average of Doppler intensities in the first five post-occlusion Doppler frames, and \({I}_{{Baseline}_{mean}}\) is the average of Doppler intensities in all of the baseline Doppler frames. Additionally, by defining a multiple (in this case 4) frame lag activation function we evaluate the delay in post-occlusion response. By cross-correlating the Doppler intensity variations with shifted versions of this activation function and finding the shifts that result in maximum correlations, we determine how many post-occlusion frames it takes for each pixel to exhibit a compensatory flow response. Subsequently, we generate maximum correlation maps showing all the pixels that exhibit a hyperemic response and through binarization (threshold of 0.6) and pixel count, estimate the total response region (TRR):
\(N_{MaxCorr}\) is the number of nonzero pixels in the binarized maximum correlation map (Fig. 1c and i), and \(A_{Image}\) is the total number of pixels (area) of the maximum correlation map/image.
Moreover, by creating maps of post-occlusion response delay (referred to as lag images) we estimate the lag-specific response regions. Lag0 response region (L0RR) corresponds to the density of pixels exhibiting an immediate increase flow following pressure release, and Lag4 (and more) response region (L4 + RR) represents the pixels for which at least 4 frames are required to manifest a compensatory response (flow increase):
\({N}_{Lag0}\) is the number of pixels corresponding to Lag0 and \({N}_{Lag4+}\) is the number of pixels corresponding to Lag4 (and more) in the lag image (Fig. 1d and j), and \({A}_{Image}\) is the total number of pixels (area) of the lag image. Consequently, PBFIV quantifies the relative increase in blood flow in response to cuff occlusion; TRR approximates the density of the pixels that exhibit a hyperemic response within a few frames post-occlusion; L0RR represents the relative size of the region where the quickest measurable response to cuff occlusion occurs; and L4 + RR shows the extent of the region where the hyperemic response (if any) takes at least 4 Doppler frames to appear.
Figure 6 shows different stages of this process. Figure 7 contains a flowchart of the entire method, from data acquisition to metric estimation for potential diagnostic applications.
Statistical analysis
The previously defined metrics were calculated for the two groups (patient legs with abnormal ABI, and healthy legs). A two-sided Wilcoxon rank sum test was implemented on the distributions of these metrics to evaluate the differences between the two groups and the corresponding p-value was computed for each metric. Differences in metrics with p-values less than 0.05 were considered to be statistically significant. Data processing and statistical analyses were performed in MATLAB R2022b (Mathworks Inc., Natick, MA, USA).
Conclusion
In this paper, we presented a contrast-free ultrasound imaging technique for monitoring the hemodynamic response to pressure cuff induced occlusion in the lower extremity of PAD patients. Metrics were defined to analyze and quantify the variations in blood flow in a baseline state, and after pressure release. These quantification metrics can be utilized to differentiate between affected and unaffected legs and potentially help with more accurate diagnosis of PAD patients before the need for more costly cross-sectional imaging approaches arises. In our future studies, we plan to recruit larger numbers of patients and perform statistical analyses on the proposed metrics to evaluate their discriminatory potential.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request. The requested data may include figures that have associated raw data. Because the study was conducted on human volunteers, the release of patient data may be restricted by Mayo policy and needs special request. The request can be sent to: Karen A. Hartman, MSN, CHRC|Administrator—Research Compliance| Integrity and Compliance Office | Assistant Professor of Health Care Administration, Mayo Clinic College of Medicine & Science | 507-538-5238 | Administrative Assistant: 507-266-6286 | hartman.karen@mayo.edu Mayo Clinic | 200 First Street SW | Rochester, MN 55905 | mayoclinic.org.m We do not have publicly available Accession codes, unique identifiers, or web links.
References
Shanmugasundaram, M. et al. Peripheral arterial disease—What do we need to know?. Clin. Cardiol. 34(8), 478–482 (2011).
Patel, T. et al. Peripheral arterial disease in women: The gender effect. Cardiovasc. Revasc. Med. 21(3), 404–408 (2020).
Criqui, M. H. et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: A scientific statement from the American Heart Association. Circulation 144(9), e171–e191 (2021).
Song, P. et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis. Lancet Glob. Health 7(8), e1020–e1030 (2019).
Shammas, N. W. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc. Health Risk Manag. 3(2), 229 (2007).
Schainfeld, R. M. Management of peripheral arterial disease and intermittent claudication. J. Am. Board Fam. Pract. 14(6), 443–450 (2001).
Hiatt, W. R. Medical treatment of peripheral arterial disease and claudication. N. Engl. J. Med. 344(21), 1608–1621 (2001).
Criqui, M. H. et al. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J. Am. Coll. Cardiol. 52(21), 1736–1742 (2008).
Smolderen, K. G. et al. Advancing peripheral artery disease quality of care and outcomes through patient-reported health status assessment: A scientific statement from the American Heart Association. Circulation 146(20), e286–e297 (2022).
Chaudhry, A. P. et al. Innovative informatics approaches for peripheral artery disease: Current state and provider survey of strategies for improving guideline-based care. Mayo Clin. Proc. Innov. Qual. Outcomes 2(2), 129–136 (2018).
Dua, A. & Lee, C. J. Epidemiology of peripheral arterial disease and critical limb ischemia. Tech. Vasc. Interv. Radiol. 19(2), 91–95 (2016).
Gerhard-Herman, M. D. et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135(12), e686–e725 (2017).
Tang, G. L., Chin, J. & Kibbe, M. R. Advances in diagnostic imaging for peripheral arterial disease. Expert Rev. Cardiovasc. Ther. 8(10), 1447–1455 (2010).
Crawford, F. et al. Ankle brachial index for the diagnosis of lower limb peripheral arterial disease. Cochrane Database of Syst. Rev. https://doi.org/10.1002/14651858.CD010680.pub2 (2016).
Arain, F. A. & Cooper Jr, L. T. Peripheral arterial disease: Diagnosis and management. Mayo Clin. Proc. 83, 944 (2008).
Kim, E., Wattanakit, K. & Gornik, H. L. Using the ankle-brachial index to diagnose peripheral artery disease and assess cardiovascular risk. Cleve Clin. J. Med. 79(9), 651–661 (2012).
Hendriks, E. J. et al. Association of high ankle brachial index with incident cardiovascular disease and mortality in a high-risk population. Arterioscler. Thromb. Vasc. Biol. 36(2), 412–417 (2016).
Resnick, H. E. et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 109(6), 733–739 (2004).
Kennedy, M. et al. Risk factors for declining ankle-brachial index in men and women 65 years or older: The cardiovascular health study. Arch. Intern. Med. 165(16), 1896–1902 (2005).
Khawaja, F. J. et al. Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations. Mayo Clin. Proc. 82, 709–716 (2007).
Xu, D. et al. Sensitivity and specificity of the ankle—Brachial index to diagnose peripheral artery disease: A structured review. Vasc. Med. 15(5), 361–369 (2010).
Doobay, A. V. & Anand, S. S. Sensitivity and specificity of the ankle–brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler. Thromb. Vasc. Biol. 25(7), 1463–1469 (2005).
Englund, E. K. et al. Multiparametric assessment of vascular function in peripheral artery disease: dynamic measurement of skeletal muscle perfusion, blood-oxygen-level dependent signal, and venous oxygen saturation. Circ. Cardiovasc. Imaging 8(4), e002673 (2015).
Tehan, P. E., Bray, A. & Chuter, V. H. Non-invasive vascular assessment in the foot with diabetes: Sensitivity and specificity of the ankle brachial index, toe brachial index and continuous wave Doppler for detecting peripheral arterial disease. J. Diabet. Complicat. 30(1), 155–160 (2016).
Abouhamda, A., Alturkstani, M. & Jan, Y. Lower sensitivity of ankle-brachial index measurements among people suffering with diabetes-associated vascular disorders: A systematic review. SAGE Open Med. 7, 2050312119835038 (2019).
Potier, L. et al. Ankle-to-brachial ratio index underestimates the prevalence of peripheral occlusive disease in diabetic patients at high risk for arterial disease. Diabetes Care 32(4), e44–e44 (2009).
Álvaro-Afonso, F. J. et al. What is the clinical utility of the ankle-brachial index in patients with diabetic foot ulcers and radiographic arterial calcification?. Int. J. Low. Extrem. Wounds 14(4), 372–376 (2015).
Aboyans, V. et al. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J. Vasc. Surg. 48(5), 1197–1203 (2008).
Cisek, P. L. et al. Microcirculatory compensation to progressive atherosclerotic disease. Ann. Vasc. Surg. 11(1), 49–53 (1997).
Kabbani, M. et al. Impact of diabetes and peripheral arterial occlusive disease on the functional microcirculation at the plantar foot. Plast. Reconstr. Surg. Global Open 1(7), e48 (2013).
Rossi, M. et al. Acute effect of exercise-induced leg ischemia on cutaneous vasoreactivity in patients with stage II peripheral artery disease. Microvasc. Res. 64(1), 14–20 (2002).
Urbančič-Rovan, V. et al. Macro-and microcirculation in the lower extremities—possible relationship. Diabetes Res. Clin. Pract. 73(2), 166–173 (2006).
Larsen, R. G. et al. Impaired microvascular reactivity after eccentric muscle contractions is not restored by acute ingestion of antioxidants or dietary nitrate. Physiol. Rep. 7(13), e14162 (2019).
Cooke, J. P. & Losordo, D. W. Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ. Res. 116(9), 1561–1578 (2015).
Meru, A. V. et al. Intermittent claudication: An overview. Atherosclerosis 187(2), 221–237 (2006).
Muir, R. L. Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention. J. Vasc. Nurs. 27(2), 26–30 (2009).
Lin, J. B. et al. Imaging of small animal peripheral artery disease models: Recent advancements and translational potential. Int. J. Mol. Sci. 16(5), 11131–11177 (2015).
Mathew, R. C. & Kramer, C. M. Recent advances in magnetic resonance imaging for peripheral artery disease. Vasc. Med. 23(2), 143–152 (2018).
Versluis, B. et al. Magnetic resonance imaging in peripheral arterial disease: Reproducibility of the assessment of morphological and functional vascular status. Invest. Radiol. 46(1), 11–24 (2011).
Wu, W.-C. et al. Skeletal muscle microvascular flow in progressive peripheral artery disease: Assessment with continuous arterial spin-labeling perfusion magnetic resonance imaging. J. Am. Coll. Cardiol. 53(25), 2372–2377 (2009).
Sah, B.-R. et al. CT-perfusion in peripheral arterial disease–Correlation with angiographic and hemodynamic parameters. PLoS ONE 14(9), e0223066 (2019).
Veit-Haibach, P. et al. CT perfusion in peripheral arterial disease—hemodynamic differences before and after revascularisation. Eur. Radiol. 31(8), 5507–5513 (2021).
Collins, R. et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol. Assessment 11(20), iii–184 (2007).
Lawall, H. et al. The diagnosis and treatment of peripheral arterial vascular disease. Dtsch. Arztebl. Int. 113(43), 729 (2016).
Tanter, M. & Fink, M. Ultrafast imaging in biomedical ultrasound. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 61(1), 102–119 (2014).
Bayat, M., Fatemi, M. & Alizad, A. Background removal and vessel filtering of noncontrast ultrasound images of microvasculature. IEEE Trans. Biomed. Eng. 66(3), 831–842 (2018).
Ghavami, S. et al. Quantification of morphological features in non-contrast-enhanced ultrasound microvasculature imaging. IEEE Access 8, 18925–18937 (2020).
Ternifi, R. et al. Quantitative biomarkers for cancer detection using contrast-free ultrasound high-definition microvessel imaging: Fractal dimension, murray’s deviation, bifurcation angle & spatial vascularity pattern. IEEE Trans. Med. Imaging 40(12), 3891–3900 (2021).
Ma, K. F. et al. A systematic review of diagnostic techniques to determine tissue perfusion in patients with peripheral arterial disease. Expert Rev. Med. Devices 16(8), 697–710 (2019).
Chen, L.-L. et al. Utility of contrast-enhanced ultrasound for the assessment of skeletal muscle perfusion in diabetes mellitus: A meta-analysis. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 25, 4535 (2019).
Lindner, J. R. et al. Limb stress-rest perfusion imaging with contrast ultrasound for the assessment of peripheral arterial disease severity. JACC Cardiovasc. Imaging 1(3), 343–350 (2008).
Duerschmied, D. et al. Contrast ultrasound perfusion imaging of lower extremities in peripheral arterial disease: A novel diagnostic method. Eur. Heart J. 27(3), 310–315 (2006).
Thomas, K. N. et al. Reliability of contrast-enhanced ultrasound for the assessment of muscle perfusion in health and peripheral arterial disease. Ultrasound Med. Biol. 41(1), 26–34 (2015).
Meneses, A. L. et al. Leg blood flow and skeletal muscle microvascular perfusion responses to submaximal exercise in peripheral arterial disease. Am. J. Physiol. Heart Circ. Physiol. 315(5), H1425–H1433 (2018).
Amarteifio, E. et al. Dynamic contrast-enhanced ultrasound and transient arterial occlusion for quantification of arterial perfusion reserve in peripheral arterial disease. Eur. J. Radiol. 81(11), 3332–3338 (2012).
Isbell, D. C. et al. Calf muscle perfusion at peak exercise in peripheral arterial disease: Measurement by first-pass contrast-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging 25(5), 1013–1020 (2007).
Met, R. et al. Diagnostic performance of computed tomography angiography in peripheral arterial disease: A systematic review and meta-analysis. JAMA 301(4), 415–424 (2009).
Hou, X. X., Chu, G. H. & Yu, Y. Prospects of contrast-enhanced ultrasonography for the diagnosis of peripheral arterial disease: A meta-analysis. J. Ultrasound Med. 37(5), 1081–1090 (2018).
Lopez, D. et al. Arterial spin labeling perfusion cardiovascular magnetic resonance of the calf in peripheral arterial disease: Cuff occlusion hyperemia vs exercise. J. Cardiovasc. Magn. Reson. 17(1), 1–9 (2015).
Sanada, H. et al. Vascular function in patients with lower extremity peripheral arterial disease: A comparison of functions in upper and lower extremities. Atherosclerosis 178(1), 179–185 (2005).
Song, P. et al. Noise equalization for ultrafast plane wave microvessel imaging. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 64(11), 1776–1781 (2017).
Nayak, R., Fatemi, M. & Alizad, A. Adaptive background noise bias suppression in contrast-free ultrasound microvascular imaging. Phys. Med. Biol. 64(24), 245015 (2019).
Funding
This study was supported in part by the National Institutes of Health (NIH) grants R01HL148664 and R01CA239548. The content is solely the responsibility of the authors and does not represent the official views of funding agencies.
Author information
Authors and Affiliations
Contributions
A.A. contributed to conceptualization, methodology, investigation, visualization, resources, funding acquisition, supervision, and project administration, reviewing and editing the manuscript; M.F. contributed to conceptualization, methodology, investigation, visualization, resources, funding acquisition, supervision, and project administration, reviewing and editing the manuscript; S.S. wrote the original draft of manuscript, contributed to data acquisition and data curation, visualization, formal analysis, software, reviewing and editing the manuscript; R.N. contributed to data acquisition and data curation, visualization reviewing and editing the manuscript, R.D.M contributed to validation and reviewing editing the manuscript. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sabeti, S., Nayak, R., McBane, R.D. et al. Contrast-free ultrasound imaging for blood flow assessment of the lower limb in patients with peripheral arterial disease: a feasibility study. Sci Rep 13, 11321 (2023). https://doi.org/10.1038/s41598-023-38576-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-38576-x
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.